Japan’s yen is under pressure, prompting officials to consider intervention and potential rate hikes to stabilize the currency amidst global economic uncertainties.
Vedanta is set to split into five companies, aiming to unlock shareholder value and improve operational efficiency. This strategic move is expected to enhance growth opportunities.
Eli Lilly has signed a $2.75 billion partnership with InSilico Medicine to enhance drug discovery through AI technology, marking a significant industry milestone.
Vedanta Limited has approached the Supreme Court to challenge Adani Group’s resolution plan for Jaiprakash Associates, raising significant corporate concerns.